Literature DB >> 29527821

On the relationship status for Arf and NPM1 - it's complicated.

Diana M Mitrea1, Richard W Kriwacki1,2.   

Abstract

Arf levels are tightly regulated in cells and correlate with the level of ribosome biogenesis and proliferative status of cells. Through multivalent interactions with NPM1 - a regulator of ribosome biogenesis, and Mdm2 - a regulator of cellular fate, Arf integrates within the nucleolar matrix, altering its structure, dynamics and function and therefore modulates the cell cycle.
© 2018 Federation of European Biochemical Societies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29527821      PMCID: PMC5965676          DOI: 10.1111/febs.14407

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  21 in total

Review 1.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

2.  p53-independent functions of the p19(ARF) tumor suppressor.

Authors:  J D Weber; J R Jeffers; J E Rehg; D H Randle; G Lozano; M F Roussel; C J Sherr; G P Zambetti
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

3.  Defining the molecular basis of Arf and Hdm2 interactions.

Authors:  B Bothner; W S Lewis; E L DiGiammarino; J D Weber; S J Bothner; R W Kriwacki
Journal:  J Mol Biol       Date:  2001-11-23       Impact factor: 5.469

4.  Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.

Authors:  M A Lohrum; M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Curr Biol       Date:  2000-05-04       Impact factor: 10.834

5.  Structural polymorphism in the N-terminal oligomerization domain of NPM1.

Authors:  Diana M Mitrea; Christy R Grace; Marija Buljan; Mi-Kyung Yun; Nicholas J Pytel; John Satumba; Amanda Nourse; Cheon-Gil Park; M Madan Babu; Stephen W White; Richard W Kriwacki
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

6.  Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.

Authors:  Enrico Luchinat; Sara Chiarella; Mimma Franceschini; Adele Di Matteo; Maurizio Brunori; Lucia Banci; Luca Federici
Journal:  FEBS J       Date:  2018-01-15       Impact factor: 5.542

7.  Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

Authors:  T Kamijo; F Zindy; M F Roussel; D E Quelle; J R Downing; R A Ashmun; G Grosveld; C J Sherr
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

8.  Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.

Authors:  David Bertwistle; Masataka Sugimoto; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function.

Authors:  Anthony J Apicelli; Leonard B Maggi; Angela C Hirbe; Alexander P Miceli; Mary E Olanich; Crystal L Schulte-Winkeler; Anthony J Saporita; Michael Kuchenreuther; José Sanchez; Katherine Weilbaecher; Jason D Weber
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

10.  Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA.

Authors:  Diana M Mitrea; Jaclyn A Cika; Clifford S Guy; David Ban; Priya R Banerjee; Christopher B Stanley; Amanda Nourse; Ashok A Deniz; Richard W Kriwacki
Journal:  Elife       Date:  2016-02-02       Impact factor: 8.140

View more
  6 in total

Review 1.  Nucleophosmin in Its Interaction with Ligands.

Authors:  Ilaria Cela; Adele Di Matteo; Luca Federici
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

2.  NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization.

Authors:  Markéta Šašinková; Petr Heřman; Aleš Holoubek; Dita Strachotová; Petra Otevřelová; Dana Grebeňová; Kateřina Kuželová; Barbora Brodská
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 3.  Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy.

Authors:  Jian Kang; Natalie Brajanovski; Keefe T Chan; Jiachen Xuan; Richard B Pearson; Elaine Sanij
Journal:  Signal Transduct Target Ther       Date:  2021-08-30

Review 4.  The nucleolus, an ally, and an enemy of cancer cells.

Authors:  Dariusz Stępiński
Journal:  Histochem Cell Biol       Date:  2018-08-13       Impact factor: 4.304

5.  Mutations of Intrinsically Disordered Protein Regions Can Drive Cancer but Lack Therapeutic Strategies.

Authors:  Bálint Mészáros; Borbála Hajdu-Soltész; András Zeke; Zsuzsanna Dosztányi
Journal:  Biomolecules       Date:  2021-03-04

6.  Next-generation sequencing in two cases of de novo acute basophilic leukaemia.

Authors:  Takuya Shimizu; Tadakazu Kondo; Yasuhito Nannya; Mizuki Watanabe; Toshio Kitawaki; Takero Shindo; Masakatsu Hishizawa; Kouhei Yamashita; Seishi Ogawa; Akifumi Takaori-Kondo
Journal:  J Cell Mol Med       Date:  2021-06-16       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.